Evaxion A (EVAX) Cash from Operations (2020 - 2022)
Evaxion A's (EVAX) quarterly Cash from Operations came in at 5190000.0 in Q2 2022, up 54.96% YoY from 3349259.07 in Q2 2021, and up 36.6% on a QoQ basis from 8186000.0 in Q1 2022.
Evaxion A (EVAX) Cash from Operations (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Cash from Operations data on file, last reported at 5190000.0 in Q2 2022.
- Quarterly Cash from Operations rose 54.96% year-over-year to 5190000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was 42717000.0 (down 48.17% YoY) and the FY2025 annual result came in at 8449000.0, up 35.69% from the prior year.
- Cash from Operations rose to 5190000.0 in Q2 2022, from 8186000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2950000.0 in Q1 2020 to a low of 17818000.0 in Q3 2021.
- A 3-year average of 7871625.0 and a median of 6635500.0 in 2020 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 122.22% — and 2022, when it soared 54.96%.
- Tracing EVAX's Cash from Operations over 3 years: stood at 8018000.0 in 2020, then slumped by 122.22% to 17818000.0 in 2021, then soared by 70.87% to 5190000.0 in 2022.
- The last three Cash from Operations figures came in at 5190000.0 (Q2 2022), 8186000.0 (Q1 2022), and 17818000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 728.46 Mn |
| 10 | Evaxion A | 27.52 Mn | 27.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.19 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -8.19 Mn |
| Mar 31, 2022 | -8.19 Mn |
| Sep 30, 2021 | -17.82 Mn |
| Sep 30, 2021 | -17.82 Mn |
| Jun 30, 2021 | -11.52 Mn |
| Jun 30, 2021 | -11.52 Mn |
| Mar 31, 2021 | -4.04 Mn |
| Mar 31, 2021 | -4.04 Mn |
| Sep 30, 2020 | -8.02 Mn |
| Sep 30, 2020 | -8.02 Mn |
| Jun 30, 2020 | -5.25 Mn |
| Jun 30, 2020 | -5.25 Mn |
| Mar 31, 2020 | -2.95 Mn |
| Mar 31, 2020 | -2.95 Mn |